These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation]. Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352 [TBL] [Abstract][Full Text] [Related]
45. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center. Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948 [TBL] [Abstract][Full Text] [Related]
46. Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma. Uthup S; Balachandran K; Ammal VA; Abdul Salam R; George J; Nair GM; Leela M Am J Kidney Dis; 2006 Aug; 48(2):e17-24. PubMed ID: 16860182 [TBL] [Abstract][Full Text] [Related]
47. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome]. Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703 [TBL] [Abstract][Full Text] [Related]
49. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526 [TBL] [Abstract][Full Text] [Related]
50. Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome. Karam C; Klein CJ; Dispenzieri A; Dyck PJ; Mandrekar J; D'Souza A; Mauermann ML Neurology; 2015 May; 84(19):1981-7. PubMed ID: 25878176 [TBL] [Abstract][Full Text] [Related]
51. [Ixazomib-Based Regimen Followed by Autologous Hematopoietic Stem Cell Transplantation in the Treatment of POEMS Syndrome]. Cheng P; Wang LL; Guan J; Zhou Y; Wang QX; Cheng H; Zou L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):937-942. PubMed ID: 35680830 [TBL] [Abstract][Full Text] [Related]
52. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420 [TBL] [Abstract][Full Text] [Related]
53. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis. Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045 [TBL] [Abstract][Full Text] [Related]
54. Neurologic improvement after peripheral blood stem cell transplantation in poems. Sabatelli M; Luigetti M; Laurenti L; Conte A; Madia F; De Matteis S; Chiusolo P; Tarnani M; Sica S Neurology; 2009 Oct; 73(14):1165; author reply 1165-6. PubMed ID: 19805738 [No Abstract] [Full Text] [Related]